Real-world Multicenter Analysis of Clinical Outcomes and Safety of Meropenem-Vaborbactam in Patients Treated for Serious Gram-Negative Bacterial Infections

Fourty patients were treated with meropenem-vaborbactam (MEV) for serious Gram-negative bacterial (GNB) infections. Carbapenem-resistant Enterobacteriaceae (CRE) comprised 80.0% of all GNB infections. Clinical success occurred in 70.0% of patients. Mortality and recurrence at 30 days were 7.5% and 1...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Alosaimy, Sara, Jorgensen, Sarah C J, Lagnf, Abdalhamid M, Melvin, Sarah, Mynatt, Ryan P, Carlson, Travis J, Garey, Kevin W, Allen, David, Venugopalan, Veena, Veve, Michael, Athans, Vasilios, Saw, Stephen, Yost, Christine N, Davis, Susan L, Rybak, Michael J
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Brief Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7060146/
https://ncbi.nlm.nih.gov/pubmed/32161775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa051
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados